Huaqin Co., Ltd. (03296): Hong Kong Public Offering Over-Subscribed by 531.33 Times, Issue Price per Share at HKD 77.7

22:29 22/04/2026

Huahin Technology (03296) announced the results of its share placement. The company sold a total of 58.5482 million H shares globally, with 10% sold in the Hong Kong public offering and 90% sold in the international offering. The offer price per share was HKD 77.7, raising approximately HKD 4.463 billion in net proceeds from the global offering. Each board lot consists of 100 shares, and it is expected that the H shares will begin trading on the Stock Exchange of Hong Kong at 9:00 am on April 23, 2026.

Huaqin Co., Ltd. (03296) announces the distribution results, with a total of 58.54 million H shares sold globally. The public offering in Hong Kong accounts for 10% and the international offering accounts for 90%. The sale price per share is HK$77.7, with a net fundraising of approximately HK$4.463 billion from the global offering. Each lot consists of 100 shares, and it is expected that the H shares will start trading on the Hong Kong Stock Exchange on April 23, 2026, at 9:00 am local time. The public offering in Hong Kong was oversubscribed by 531.33 times, while the international offering was oversubscribed by 13.34 times.

US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.

US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.

JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.

SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.